Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato

Key facts

Sponsor

University Medical Centre Ljubljana

Enrollment

15000 target

Eligibility

18 years · All sexes

Timeline

2024 – 2027

Study locations (1)

• Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Lyme disease

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT06785402
  Ceftriaxone for Post-Treatment Lyme Disease
  Hackensack Meridian Health
• RECRUITINGPHASE3NCT07226882
  A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
  Pfizer
• RECRUITINGPHASE4NCT06451913
  Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
  Biocodex
• RECRUITINGNANCT06915324
  Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
  Columbia University
• RECRUITINGEARLY PHASE1NCT06611111
  Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
  State University of New York - Upstate Medical University
• ACTIVE NOT RECRUITINGNCT06731179
  A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay
  ViraxBio Labs
• RECRUITINGPHASE1, PHASE2NCT06511050
  Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  Icahn School of Medicine at Mount Sinai
• RECRUITINGNANCT06655844
  Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain
  Icahn School of Medicine at Mount Sinai

See all trials for Lyme disease →